Abstract
Multiple clinical studies have shown that bardoxolone methyl, a potent activator of nuclear factor erythroid 2-related factor 2 (Nrf2), is effective i......
小提示：本篇文献需要登录阅读全文，点击跳转登录
Full Text Link
